2021
DOI: 10.1016/j.urolonc.2020.09.030
|View full text |Cite
|
Sign up to set email alerts
|

A national cross-sectional survey of financial toxicity among bladder cancer patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
25
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 25 publications
(26 citation statements)
references
References 27 publications
1
25
0
Order By: Relevance
“…In this study, age and household size were associated with financial toxicity. Patients with increased age had a lower probability of having financial toxicity, which is consistent with the results of previous studies [ 22 , 41 43 ]. Younger adults may not have additional resources such as retirement funds or home equity to ease their financial burden [ 44 ].…”
Section: Discussionsupporting
confidence: 92%
“…In this study, age and household size were associated with financial toxicity. Patients with increased age had a lower probability of having financial toxicity, which is consistent with the results of previous studies [ 22 , 41 43 ]. Younger adults may not have additional resources such as retirement funds or home equity to ease their financial burden [ 44 ].…”
Section: Discussionsupporting
confidence: 92%
“…31 Furthermore, health utilities were estimated in 3 of 5 studies that measured HRQOL using EQ-5D instruments. [59][60][61] Findings of these studies suggest that there is a significant association between financial toxicity and utility loss, and therefore, it may be possible that the mitigation of financial toxicity improves quality-adjusted life-year gains in patients with cancer and survivors.…”
Section: Discussionmentioning
confidence: 99%
“… 25 Additionally, patients with lung cancer in China and worldwide had higher FT compared with that for other cancer types, such as breast, bladder, and localized prostate cancers. 6 , 33 , 34 Although Universal Healthcare Coverage has existed in China since 2009, the proportion of out‐of‐pocket costs in total health expenditure is more than 25%. 35 Furthermore, with the development of innovative treatments for lung cancer such as immune and targeted therapy, treatment‐related costs continue to increase.…”
Section: Discussionmentioning
confidence: 99%